Publications

Scholarly Journals--Published

  • Wagner, M.J.; Othus, M.; Patel, S.P.; Ryan, C.; Sangal, A.; Powers, B.; Budd, G.T.; Victor, A.I.; Hsueh, C.-T.; Chugh, R.; Nair, S.; Leu, K.M.; Agulnik, M.; Sharon, E.; Mayerson, E.; Plets, M.; Blanke, C.; Streicher, H.; Chae, Y.K.; Kurzrock, R. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). J Immunother Cancer. 2021 Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990. PMID: 34380663 (08/2022) (link)
  • Chong, E.G.; Lee, E.H.; Sail, R.; Denham, L.; Nagaraj, G.; Hsueh, C.-T. Anthracycline-induced cardiotoxicity: A case report and review of literature. World J Cardiol. 2021 Jan 26;13(1):28-37. PMID: 33552401 (01/2021) (link)
  • Selim, J.H.; Shaheen, S.; Sheu, W.C.; Hsueh, C.-T. Targeted and novel therapy in advanced gastric cancer. Exp Hematol Oncol. 2019 Oct 11;8:25. PMID: 31632839  (10/2019)
  • Thinn, M.M.; Hsueh, C.T.; Hsueh, C.-T. Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report. World J Clin Cases. 2019 Mar 6;7(5):616-622. PMID: 30863760   (03/2019)
  • Midthun, L.; Shaheen, S.; Deisch, J.; Senthil, M.; Tsai, J.; Hsueh, C.-T. Concomitant KRAS and BRAF mutations in colorectal cancer. J Gastrointest Oncol 2019;10(3):577-581. (2019)
  • Kang, J.I.; Sufficool, D.C.; Hsueh, C.-T.; Wroe, A.J.; Patyal, B.; Reeves, M.E.; Slater, J.D.;  Yang, G.Y. A phase I trial of proton stereotactic body radiation therapy for liver metastases. J Gastrointest Oncol. 2019 Feb;10(1):112-117. PMID: 30788166   (2019)
  • Ahn, J.; Moyers, J.; Wong, J.; Hsueh, C.-T. Thyroid dysfunction from inhibitor of fibroblast growth factor receptor. Exp Hematol Oncol. 2019 Feb 18;8:6. PMID: 30820365   (2019)
  • Shaheen, S.; Mirshahidi, H.; Nagaraj, G.; Hsueh. C.-T. Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature. Exp Hematol Oncol. 7:11, 2018.   (2018)
  • Wu, Y.-C.; Chiu, C.-F.; Hsueh, C.-T,; Hsueh. C.-T. The role of bile acids in cellular invasiveness of gastric cancer. Cancer Cell International 18:75, 2018.   (2018)
  • Garg, N.; Stoehr, C.; Zhao, Y.S.; Rojas, H.; Hsueh. C.-T. Metastatic squamous cell carcinoma of colon from esophageal cancer. Exp Hematol Oncol. 6:11, 2017 (04/2017) (link)
  • Sarantopoulos, J.; Mita, A.C.; He, A.; Wade, J.L.; Hsueh, C.-T.; Morris, J.C.; Lockhart, A.C.; Quinn, D.I.; Hwang, J.; Mier, J.; Zhang, W.; Wack, C.; Yin, J.; Clot, P.F.; Rixe, O. Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study. Cancer Chemother Pharmacol. 79(2):339-351, 2017.  (02/2017) (link)
  • Hsueh, C.-T.; Selim, J.H.; Tsai, J.Y.; Hsueh, C.-T. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World J Gastroenterol. 22(31):7080-7090, 2016 (08/2016) (link)
  • Wong, J.; Solomon, N.L.; Hsueh, C.-T. Neoadjuvant treatment for resectable pancreatic adenocarcinoma. World J Clin Oncol. 7(1):1-8, 2016. (02/2016) (link)
  • Hsu, H.-W.; Wall, N.R.; Hsueh, C.-T.; Kim, S.; Ferris, R.L.; Chen, C.-S.; Mirshahidi, S. Combination antiangiogenic therapy and radiation in head and neck cancers. Oral Oncol. 50(1):19-26, 2014. (01/2014) (link)
  • Hsueh, C.-T.; Liu, D.; Wang, H. Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials. Biomarker Res. 1:1, 2013. (01/2013) (link)
  • Hung, J.-J.; Hsueh, C.-T.; Chen, K.-H.; Hsu, W.-H.; Wu, Y.-C. Clinical significance of E2F1 protein expression in non-small cell lung cancer. Exp. Hematol. Oncol. 1:18, 2012. (2012) (link)
  • Li, Z.; Hsueh, C.-T.; Liu, D. Publish, not perish: Introducing Experimental Hematology & Oncology. Exp. Hematol. Oncol. 1:1, 2012. (2012) (link)
  • Hsueh, E.C.; Knebel, S.M.; Lo, W.H.; Leung, Y.C.; Cheng, P.N.; Hsueh, C.-T. Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol. Oncol. 5:17, 2012. (2012) (link)
  • Yuan, Y.; Liao, Y.-M.; Hsueh, C.-T.; Mirshahidi, H.R. Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. J. Hematol. Oncol. 4:16, 2011. (04/2011 - 2011) (link)
  • Huang, C.H.; Williamson, S.K.; VanVeldhuizen, P.J.; Hsueh, C.-T.; Allen, A.; Smith, H.; Mayo, M.; Tawfik, O.; Uypeckcuat, A.M.; Kelly, K. Potential role of platelet derived growth factor receptor inhibition using imatinib in combination with docetaxel in the treatment of recurrent non-small cell lung cancer. J. Thorac. Oncol. 6:372-377, 2011. (01/2011 - 2011) (link)
  • Hsueh, C.-T. Pancreatic cancer: current standards, research updates and future directions. J. Gastrointest. Oncol. 2: 123-125, 2011. (2011) (link)
  • Pan, J.-J.; Javle, M.; Thinn, M.-M.; Hsueh, C.-T.; Hsueh, C.-T. Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma. Hepatic Medicine: Evidence and Research, 2: 147–155, 2010. (11/2010 - 2010) (link)
  • Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report. Wang J., Saukel G.W., Garberoglio C.A., Srikureja W., Hsueh C.-T. J. Hematol. Oncol. 3:31, 2010. (09/2010 - 2010) (link)
  • Wu, Y.-C.; Su, L.-J.; Wang, H.-W.; Lin, C.-F.; Hsu, W.-H.; Chou, T.-Y.: Huang, C.-Y.; Lu, C.-L.; Hsueh, C.-T. Cooverexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer. J. Thorac. Oncol. 5:1167-1174, 2010. (08/2010 - 2010) (link)
  • Bautista-Quach, M.A.; Liao, Y.-M.; Hsueh, C.-T. Pancytopenia associated with clonazepam. J. Hematol. Oncol. 3:24, 2010. (07/2010 - 2010) (link)
  • Mirshahidi, H; Hsueh, C.-T. Updates in non-small cell lung cancer - insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. J Hematol. Oncol. 3:18, 2010.       (2010) (link)
  • Bautista, M.; Stevens, W.T.; Chen, C.-S.; Curtis, B.R.; Aster, R.H.; Hsueh, C.-T. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J. Hematol. Oncol. 3:12, 2010. (2010) (link)
  • Javle, M.; Hsueh, C.-T. Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology. J. Hematol. Oncol. 3:11, 2010. (2010) (link)
  • Javle, M.; Hsueh, C.-T. Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology. J. Hematol. Oncol. 2:9, 2009 (2009) (link)
  • Acharya, U.; Gau, J.-T.; Horvath, W.; Ventura, P.; Hsueh, C.-T.; Carlsen, W. Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature. J. Hematol. Oncol. 1:26 (5 pages), 2008. (2008) (link)
  • Wang, H.-W.; Hsueh, C.-T.; Lin, C.-F.; Chou, T.-Y.; Hsu, W.-H.; Wang, L.-S.; Wu, Y.-C. Clinical implications of microsomal prostaglandin E synthase-1 overexpression in human non-small cell lung cancer. Ann. Surg. Oncol. 13:1224-1234, 2006. (09/2006) (link)
  • Wang, H.-M.; Hsueh, C.-T.; Wang, C.-S.; Chen, I.-H.; Liao, C.-T.; Tsai, M.-H.; Yeh, S.-P.; Chang,  J. T.-C. Phase II trial of cisplatin, tegafur plus uracil, and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of oropharynx and hypopharynx. Anti-Cancer Drugs. 16:447-453, 2005. (04/2005) (link)
  • Yeh, S.-P.; Liao, Y.-M.; Hsu, C.-H.; Chen, C.-L.; Shen, Y.-C.; Hsueh, C.-T.; Huang, H.-H.; Chiu, C.-F. Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessment. Am. J. Clin. Pathol. 122:919-25, 2004. (12/2004) (link)
  • Liao, Y.-M.; Chiu, C.-F.; Ho, M.-W.; Hsueh, C.-T. Fusidic acid-induced leukopenia and thrombocytopenia. J. Chin. Med. Assoc. 66:429-432, 2003. (correspondence author) (07/2003) (link)
  • Yeh, S.-P.; Chiu, C.-F.; Lo, W.-J.; Lin, C.-L.; Hsueh, C.-T.; Liao, Y.-M.; Shen, Y.-C. Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis. Ann. Hematol. 82:24-29, 2003. (01/2003) (link)
  • Tsai, M.-H.; Chow, K.-C.; Lin, T.-Y.; Yeh, S.-P.; Hsueh, C.-T.; Chi, K.-H. Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma. Oncol. Rep., 9:247-251, 2002. (03/2002) (link)
  • Hung, J.-S.; Hsueh, C.-T.; Chen, J.-J.; Su B.-H.; Chen W.; Shen W.-C. Visitor Report: Visit to the Tokyo Women Medical University. J. Med. Educ. (Taipei, Taiwan). 6:110-113, 2002. (01/2002) (link)
  • Hsueh, C.-T.; Wu, Y.-C.; Schwartz, G.K. UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation. Clin. Cancer Res. 7:669-674, 2001. (correspondence author) (03/2001) (link)
  • Hsueh, C.-T.; Chiu, C.-F.; Kelsen, D.P.; Schwartz, G.K. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis. Cancer Chemother. Pharmacol. 45:389-396, 2000. (correspondence author) (05/2000) (link)
  • Hsueh, C.-T.; Kelsen, D.P.; Schwartz, G.K. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. Clin. Cancer Res. 4:2201-2206, 1998. (09/1998) (link)
  • Dolnick, B.J.; Black, A.R.; Winkler, P.M.; Schindler, K.; Hsueh, C.-T. rTs gene associated with altered cell sensitivity to thymidylate synthase inhibitors. Adv. Enzyme Regul. 36:165-180, 1996. (01/1996) (link)
  • Hsueh, C.-T.; Dolnick, B.J. Regulation of folate-binding protein gene expression by DNA methylation in methotrexate-resistant KB cells. Biochem. Pharmacol. 47:1019-1027, 1994. (03/1994) (link)
  • Hsueh, C.-T.; Dolnick, B.J. Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium. Biochem. Pharmacol. 45:2537-2545, 1993. (06/1993) (link)
  • Hsueh, C.-T.; Dolnick, B.J. Folate-binding protein mRNA is decreased in methotrexate-resistant KB cells. Oncol. Res. 4:497-505, 1992. (11/1992) (link)
  • Johnkoski, J.A.; Hsueh, C.-T.; Doerr, R.J.; Cohen, S.A. Levamisole augments the immune response of the murine liver. Am. J. Surg. 163:202-207, 1992. (02/1992) (link)

Abstract

  • D.C. Sufficool, P. McGee, S. Swenson, C.T. Hsueh, G. Nagaraj, M.E. Reeves, J.D. Slater, G.Y. Yang. Proton SBRT for liver metastases - results of 5-year experience for 80 hepatic lesions based on NRG-BR001. International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , S165 - S166. Proceedings of American Society for Radiation Oncology annual meeting in San Antonio, TX. October 21 – 24, 2018. (10/2018)
  • J.I. Kang, R. Grove, C.T. Hsueh, A. Wroe, B. Patyal, M.E. Reeves, J.D. Slater, G.Y. Yang. A phase I trial of stereotactic body proton therapy (SBPT) for liver metastases. International Journal of Radiation Oncology • Biology • Physics , Volume 96 , Issue 2 , E209. Proceedings of American Society for Radiation Oncology annual meeting in Boston, MA. September 25 – 28, 2016. (09/2016)
  • John Sarantopoulos, Alain C. Mita, Aiwu Ruth He, James Lloyd Wade, Chung-Tsen Hsueh, John Charles Morris, Albert C. Lockhart, David Quinn, Jimmy J. Hwang, James Walter Mier, Wenping Zhang, Claudine Wack, Jian Yin, Pierre-François Clot, and Olivier Rixe. Safety and pharmacokinetics of cabazitaxel in patients (pts) with hepatic impairment. J Clin Oncol 33, No 15_suppl (May 20 Supplement), 2015: 2538. Proceedings of American Society of Clinical Oncology annual meeting in Chicago, IL. May 29 - June 02, 2015. (06/2015)
  • Kuo, C.-C.; Chen, J.-J.; Tsai, J.Y.; Hsueh, C.-T. Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells. Biomarker Res. 2:26, 2014.  (12/2014) (link)
  • Olivier Rixe, O.; Sarantopoulos, J.; Hsueh, C.-T.; Lockhart, A.C.; Ross, S.; Agarwala, S.S.; Zhang, W.; Yin, J.Y.; Wack, C.; Mazuir, F.; Gurtler, J.S. Absence of interaction of cabazitaxel on the pharmacokinetics of midazolam: Results of a drug–drug interaction study in patients with advanced solid tumors. J Clin Oncol 31, 2013 (suppl 6; abstr 126). 2013 Genitourinary Cancers Symposium in Orlando, FL. February 14-16, 2013  (02/2013)
  • Liao, Y.-M.; Mirshahidi, H.; Zhang K.; Mirshahidi, S.; Williamson, S.; Hsueh, C.-T. Phase I study of azacitidine and cisplatin in patients with advanced head and neck or non-small cell lung cancer. Proc. Am. Assoc. Cancer Res. 53: abstract# 2663, Chicago, IL. Mar 31 - Apr 4, 2012. (04/2012)
  • Hsueh, C.-T. Pancreatic cancer: current standards, research updates and future directions. J. Gastrointest. Oncol. 2: 123-125, 2011. (09/2011) (link)

Books and Chapters

  • Hsueh, C.-T. The hematological diseases. In: Kuan-Chien family encyclopedia of health (Chinese), Book Spring Press, Taipei, 2002: 494-505. (ISBN 957-648-925-3) (2002 - Present)
  • Hsueh, C.-T. Implementation of clinical skills course. In: First year of medical education reform (Chinese), published by Medical Education Reform Committee, School of Medicine, China Medical University, 2002:80-82. (2002 - Present)
  • Hsueh, C.-T. Human folate receptor: regulation of gene expression and its role in mechanisms of methotrexate resistance. Ph.D. thesis, 187 pages, State University of New York at Buffalo, 1993. (1993 - Present) (link)
  • Hsueh, C.-T.; Johnkoski, J.A.; Doerr, R.J.; Cohen, S.A. Immunopotentiating effect of levamisole in murine liver. Proc. fifth international symposium on cells of the hepatic sinusoid. In: Cells of the hepatic sinusoid, Vol. 3, The Kupffer Cell Foundation, Leiden, (E. Wisse, D.L. Knook, and R.S. McCuskey Eds.), 1991:354-357. (1991 - Present)